X-ray Psoralen Activated Cancer Therapy

· Immunolight, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for X-ray Psoralen Activated Cancer Therapy, covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma [Phase 1]